Citadel Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,714
Closed -$29.1K 7095
2023
Q4
$29.1K Buy
+2,714
New +$29.1K ﹤0.01% 5279
2023
Q3
Hold
0
6746
2023
Q2
Sell
-196
Closed -$3.07K 6717
2023
Q1
$3.07K Sell
196
-80
-29% -$1.25K ﹤0.01% 5652
2022
Q4
$5.51K Buy
+276
New +$5.51K ﹤0.01% 5767
2022
Q3
Sell
-58,148
Closed -$1.29M 6955
2022
Q2
$1.29M Buy
58,148
+48,893
+528% +$1.09M ﹤0.01% 3139
2022
Q1
$257K Buy
9,255
+5,031
+119% +$140K ﹤0.01% 5082
2021
Q4
$192K Buy
4,224
+21
+0.5% +$955 ﹤0.01% 5505
2021
Q3
$350K Buy
4,203
+782
+23% +$65.1K ﹤0.01% 4887
2021
Q2
$325K Sell
3,421
-3,808
-53% -$362K ﹤0.01% 5125
2021
Q1
$1.2M Buy
+7,229
New +$1.2M ﹤0.01% 3722
2020
Q4
Hold
0
5743
2018
Q3
Sell
-138
Closed -$296K 4840
2018
Q2
$296K Buy
+138
New +$296K ﹤0.01% 3450
2016
Q4
Sell
-39
Closed -$43K 4230
2016
Q3
$43K Buy
+39
New +$43K ﹤0.01% 3307
2016
Q2
Sell
-15
Closed -$11K 4035
2016
Q1
$11K Buy
+15
New +$11K ﹤0.01% 3247
2015
Q4
Sell
-10
Closed -$10K 4383
2015
Q3
$10K Sell
10
-11
-52% -$11K ﹤0.01% 3887
2015
Q2
$44K Buy
21
+1
+5% +$2.1K ﹤0.01% 3461
2015
Q1
$19K Buy
20
+9
+82% +$8.55K ﹤0.01% 3566
2014
Q4
$11K Sell
11
-8
-42% -$8K ﹤0.01% 3750
2014
Q3
$19K Buy
19
+4
+27% +$4K ﹤0.01% 3341
2014
Q2
$29K Buy
15
+9
+150% +$17.4K ﹤0.01% 3213
2014
Q1
$13K Buy
+6
New +$13K ﹤0.01% 3509
2013
Q4
Sell
-6
Closed -$17K 3240
2013
Q3
$17K Sell
6
-25
-81% -$70.8K ﹤0.01% 2803
2013
Q2
$284K Buy
+31
New +$284K ﹤0.01% 2130